Cost of non-alcoholic steatohepatitis in Europe and the USA: The GAIN study

Cost of non-alcoholic steatohepatitis in Europe and the USA: The GAIN study

Background & Aims: Non-alcoholic steatohepatitis (NASH) leads to cirrhosis and is associated with a substantial socioeconomic burden, which, coupled with rising prevalence, is a growing public health challenge. However, there are few real-world data available describing the impact of NASH. M...

Full description

Bibliographic Details
Main Authors: Jamie O'Hara, Alan Finnegan, Harpal Dhillon, Leonardo Ruiz-Casas, Gabriel Pedra, Bethany Franks, George Morgan, Vanessa Hebditch, Bengt Jönsson, Mzwandile Mabhala, Tatjana Reic, Ingo Van Thiel, Vlad Ratziu, Manuel Romero-Gomez, Elisabetta Bugianesi, Jörn M. Schattenberg, Quentin M. Anstee
Format: Article
Language:English
Published: Elsevier 2020-10-01
Series:JHEP Reports
Subjects:
Non-alcoholic steatohepatitis
Cost of illness
Cross-sectional studies
Europe
Online Access:http://www.sciencedirect.com/science/article/pii/S2589555920300768

Internet

http://www.sciencedirect.com/science/article/pii/S2589555920300768

Similar Items